Arias, L., & Monés, J. (2010). Transconjunctival sutureless vitrectomy with tissue plasminogen activator, gas and intravitreal bevacizumab in the management of predominantly hemorrhagic age-related macular degeneration. Dove Medical Press.
Cita Chicago Style (17a ed.)Arias, Luis, y Jordi Monés. Transconjunctival Sutureless Vitrectomy with Tissue Plasminogen Activator, Gas and Intravitreal Bevacizumab in the Management of Predominantly Hemorrhagic Age-related Macular Degeneration. Dove Medical Press, 2010.
Cita MLA (8a ed.)Arias, Luis, y Jordi Monés. Transconjunctival Sutureless Vitrectomy with Tissue Plasminogen Activator, Gas and Intravitreal Bevacizumab in the Management of Predominantly Hemorrhagic Age-related Macular Degeneration. Dove Medical Press, 2010.